18 reports

The drug candidate acts by targeting pollen allergen Bet v ##.

  • Allergy
  • Cardiovascular Disease
  • Therapy
  • Company
  • Product Initiative

The drug candidate acts by targeting pollen allergen Bet v ##.

  • Allergy
  • Cardiovascular Disease
  • Therapy
  • Company
  • Product Initiative

Cat allergy is an allergic reaction to one or more allergens produced by cats.

  • Allergy
  • Cardiovascular Disease
  • World
  • Company
  • Product Initiative

PATIENTS WERE RANDOMIZED IN A ##:## FASHION TO ACTIVE DRUG VERSUS PLACEBO.

  • Allergy
  • Cardiovascular Disease
  • Therapy
  • Company
  • Product Initiative

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Cardiovascular Disease
  • Therapy
  • Company
  • Product Initiative

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Therapy
  • Company
  • Product Initiative
  • Biomay AG

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Biotechnology
  • Cardiovascular Disease
  • Company
  • Product Initiative

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Therapy
  • Company
  • Product Initiative
  • Biomay AG

About ## percent of people who have food allergies are allergic to more than one food.

  • Allergy
  • Therapy
  • Vaccine
  • Company
  • Product Initiative

Cat allergy is an allergic reaction to one or more allergens produced by cats.

  • Allergy
  • Cardiovascular Disease
  • World
  • Company
  • Product Initiative

" House dust mite allergy is one of the most common allergies, impacting the quality of life for patients across ages and geographies.

  • Allergy
  • Allergy Immunotherapy
  • Therapy
  • Company
  • Product Initiative

HOUSE DUST MITE ALLERGY - PIPELINE BY STALLERGENES GREER PLC, H## 2019 House Dust Mite Allergy - Drug Profiles ALLERGAN FOR DUST MITE ALLERGY - DRUG PROFILE ALLERGEN FOR ALLERGIC ASTHMA AND HOUSE DUST MITE ALLERGY - DRUG PROFILE AM-## -

  • Allergy
  • Allergy Immunotherapy
  • Therapy
  • Company
  • Product Initiative

BIOLOGIC FOR CEDAR POLLEN ALLERGY - DRUG PROFILE OMALIZUMAB - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description omalizumab F.

  • Allergy
  • Therapy
  • Vaccine
  • Company
  • Product Initiative

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Biotechnology
  • Cardiovascular Disease
  • Company
  • Product Initiative

HALMRE-## - DRUG PROFILE POLLINEX QUATTRO GRASS - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Pollinex Quattro Grass Allergy Therapeutics Plc NA GlaxoSmithKline Plc R& D Progress Resea

  • Allergy
  • Allergy Drug
  • Ophthalmic Solution
  • Company
  • Product Initiative

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Allergy
  • Cardiovascular Disease
  • Cell Therapy
  • Company
  • Product Initiative

The drug candidate activates allergen-specific T-helper type ## (Th##) cellular responses with the production of interferons by antigen presenting cells (APC), natural killer cells (NK), and T cells.

  • Allergy
  • Allergy Drug
  • Cardiovascular Disease
  • Company
  • Product Initiative

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Allergy
  • Antifungal
  • Cardiovascular Disease
  • Company
  • Product Initiative